Bayer AG – Product Pipeline Review – 2013

Date: May 27, 2013
Pages: 485
Price:
US$ 1,500.00
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: BB6C9F04A02EN
Leaflet:

Download PDF Leaflet

Bayer AG – Product Pipeline Review – 2013
Bayer AG – Product Pipeline Review – 2013

Summary

Global Market Direct’s pharmaceuticals report, “Bayer AG - Product Pipeline Review - 2013” provides data on the Bayer AG’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Bayer AG’s corporate website, SEC filings, investor presentations and featured press releases, both from Bayer AG and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope
  • Bayer AG - Brief Bayer AG overview including business description, key information and facts, and its locations and subsidiaries.
  • Review of current pipeline of Bayer AG human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of Bayer AG with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Recent updates of the Bayer AG’s pipeline in the last quarter.
  • Key discontinued and dormant projects.
  • Latest news and deals relating to the products.
  • Evaluate Bayer AG’s strategic position with total access to detailed information on its product pipeline.
  • Assess the growth potential of Bayer AG in its therapy areas of focus.
  • Identify new drug targets and therapeutic classes in the Bayer AG’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
  • Exploit collaboration and partnership opportunities with Bayer AG.
  • Avoid Intellectual Property Rights related issues.
  • Explore the dormant and discontinued projects of Bayer AG and identify potential opportunities in those areas.
Bayer AG Snapshot
Bayer AG Overview
Key Information
Key Facts
Bayer AG – Research and Development Overview
Key Therapeutic Areas
Bayer AG – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Bayer AG – Pipeline Products Glance
Bayer AG – Late Stage Pipeline
Bayer AG Clinical Stage Pipeline Products
Bayer AG – Early Stage Pipeline Products
Bayer AG – Drug Profiles
(gestodene + ethinyl estradiol)
(naproxen sodium + diphenhydramine hydrochloride)
(nifedipine + candesartan cilexetil)
amikacin
aspirin
BAY-1000394
BAY-1001931
BAY-1002670
BAY-1021189
BAY-1026153
BAY-1067197
BAY-1082439
BAY-1125976
BAY-60-5521
BAY-606583
BAY-806946
BAY-818973
Bay-846
BAY-85-3934
BAY-858501
BAY-868050
BAY-94-8862
BAY-94-9343
BAY-949027
BR-5489
ciprofloxacin
lonaprisan
mapracorat
Modified FOLFOX6 + Nexavar
nelociguat
prasterone
radium Ra 223 dichloride
refametinib
regorafenib
Regorafenib + FOLFIRI
Regorafenib + mFOLFOX6
riociguat
rivaroxaban
sagopilone
Selective Kinase Inhibitor Program
SMOLs
sorafenib tosylate
ZK-191784
Bayer AG – Pipeline Analysis
Bayer AG – Pipeline Products by Therapeutic Class
Bayer AG – Pipeline Products by Route of Administration
Bayer AG – Pipeline Products By Mechanism of Action
Bayer AG – Recent Pipeline Updates
Bayer AG - Dormant Projects
Bayer AG - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
Bayer AG – Company Statement
Bayer AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Bayer AG, Recent Developments
Bayer AG- Press Release
Financial Deals Landscape
Bayer AG, Deals Summary
Bayer AG, Pharmaceuticals & Healthcare, Deal Details
Asset Transactions
Venture Financing
Partnerships
Licensing Agreements
Debt Offering
Asset Transactions
Acquisition
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

Bayer AG, Key Information
Bayer AG, Key Facts
Bayer AG – Pipeline by Indication, 2013
Bayer AG – Pipeline by Stage of Development, 2013
Bayer AG – Monotherapy Products in Pipeline, 2013
Bayer AG – Combination Treatment Modalities in Pipeline, 2013
Bayer AG – Filed, 2013
Bayer AG – Phase III, 2013
Bayer AG – Phase II, 2013
Bayer AG – Phase I, 2013
Bayer AG – Pre-Clinical, 2013
Bayer AG – Discovery, 2013
Bayer AG – Pipeline By Therapeutic Class, 2013
Bayer AG – Pipeline By Route of Administration, 2013
Bayer AG – Pipeline Products By Mechanism of Action, 2013
Bayer AG – Recent Pipeline Updates, 2013
Bayer AG - Dormant Developmental Projects,2013
Bayer AG - Discontinued Pipeline Products, 2013
Bayer AG, Subsidiaries
Bayer AG, Deals Summary
Bayer Acquires Preclinical Anti-cancer Program From Nycomed
Bayer HealthCare Acquires Western OTC Cough And Cold Business From Topsun Science and Technology
Bayer HealthCare Acquires MAXY-VII From Maxygen
Bayer HealthCare Acquires OTC Business Of Sagmel
Bayer HealthCare Acquires Citracal From Mission Pharmacal Company
Bayer Schering Pharma Acquires US Biologics Manufacturing Facility From Novartis
AiCuris Raises US$75 Million In Second Round Of Venture Financing
ChromoTek Enters Into Licensing Agreement With Bayer For Cell Cycle Chromobody Technology
MEDRAD Enters Into Licensing Agreement With B. Braun Melsungen
Bayer Schering Pharma Enters Into Licensing Agreement With Hamamatsu Photonics
Bayer Schering Pharma Signs An Agreement With Nagasaki University
Bayer HealthCare Extends Co-Development Agreement With German Cancer Research Center
Bayer HealthCare Enters Into Research Agreement With Children’s Hospital & Research Center
Bayer HealthCare Enters Into Distribution Agreement With Comecer For Medrad Intego PET Infusion System
Bayer HealthCare Enters Into Agreement With Medsintez
Qiagen Enters Into Agreement With Bayer HealthCare To Develop Diagnostics Test In Oncology
Bayer Enters Into Co-Development Agreement With Evotec For Endometriosis Drugs
Horizon Discovery Enters Into Co-Development Agreement With Bayer Pharma For Human Isogenic Cell Lines
Bayer HealthCare Enters Into Co-Marketing Agreement With Radimetrics For eXposure
Bioton And SciGen Amend Distribution Agreement With Bayer HealthCare
Bayer HealthCare Enters Into Agreement With Covance
Regeneron Pharma And Bayer Yakuhin Enter Into Co-Promotion Agreement With Santen Pharma For Eylea
Bayer HealthCare Enters Into Co-Development Agreement With Amgen Research
Algeta Exercises Option Agreement With Bayer To Co-Promote Alpharadin
Bayer Healthcare Enters Into Co-Development Agreement With Tsinghua University
Bayer Yakuhin Enters Into Distribution Agreement With Femasys For FemVue Saline-Air Device
Bayer HealthCare And Almirall Enter Into Co-Promotion Agreement For Rivaroxaban In Spain
Ventana Medical Systems Enters Into Co-Development Agreement With Bayer Pharma
Bayer HealthCare Pharma Enters Into Research Agreement With Ludwig Boltzmann Institute
MediSapiens Enters Into Co-Development Agreement With Bayer HealthCare Pharma
Bayer Enters Into Joint Venture Agreement With Yunona Holdings
Dong-A Pharma Enters Into Co-Marketing Agreement With Bayer Korea
Bayer Enters Into Research Agreement With Ludwig Boltzmann, Nebu-Tec, And Austrian Academy
Bayer Vital Signs Agreement With Vital Images
Bayer HealthCare Enters Into Joint Venture Agreement With Zydus Cadila Healthcare
Bayer HealthCare Extends Co-Development Agreement With German Cancer Research Center
Bayer HealthCare Enters Into Research Agreement With University of California
Bayer Schering Pharma Enters Into Research Agreement With University of California, San Francisco
HANDOK Pharma Enters Into Co-Marketing Agreement With Bayer Korea
Cancer Targeted Enters Into Research And License Option Agreement With Bayer Pharma
Bayer HealthCare Enters Into An Agreement With NUS, NUHS, SingHealth And SBIC
Bayer Schering Pharma Enters Into An Agreement With National Pharma Engineering Research Center
Ligon Discovery Enters Into Collaboration With Bayer Schering Pharma
Astellas Pharma Enters Into Co-Marketing Agreement With Bayer Schering Pharma
MEDRAD Enters Into A Distribution Agreement With WFR-AQUAPLAST And Qfix Systems
Bayer Schering Pharma Enters Into Research Agreement With The People's Liberation Army General Hospital
Bayer Schering Pharma Enters Into Strategic Alliance With OncoMed Pharma
Bayer Schering Pharma Enters Into An Agreement With Protagen
TauRx Pharma Enters Into Co-development Agreement With Bayer Schering Pharma
Bayer Schering Enters Into Co-Development Agreement With Micromet
MicroDiscovery Extends Collaboration With Bayer Schering
Merge Healthcare Expands European Distribution Agreement With MEDRAD
Bayer Schering Pharma Enters Into Agreement With AC Immune
MEDRAD Enters Into Research Agreement With The University of South Florida And Moffitt Cancer Center
Bayer Schering Pharma Enters Into Distribution Agreement With BIOTON And SciGen
HRA Pharma Enters Into Agreement with Bayer
Neptune Technologies Enters Into An Agreement With Bayer Healthcare
Neptune Technologies & Bioressources Signs An Agreement With Bayer Healthcare
Bayer CropScience Enters Into Research Agreement With IVCC
Bayer HealthCare Extends Collaboration With Regeneron Pharma
Bayer HealthCare Enters Into Joint Venture Agreement With Tsinghua University
MEDRAD Signs Research Agreement With University of Zurich
Tyrian Diagnostics Enters Into Co-Development Agreement With Bayer CropScience
innovatis Enters Into Co-Marketing Agreement With Bayer Technology Services
Bayer Schering Pharma Enters Into Co-Development Agreement With German Cancer Research Center
Genedata Expands Research Agreement With Bayer Schering Pharma
Sartorius Stedim Biotech Enters Into Co-Marketing Agreement With Bayer Technology Services
Bayer Schering Pharma Enters Into Co-Development Agreement With National University of Singapore
Confirma Signs An Agreement With MEDRAD
Fujifilm RI Pharma Enters Into Co-Marketing Agreement With Bayer Yakuhin For Zevalin
Cell Therapeutics Enters Into Agreement With Bayer Schering Pharma
MEDRAD Enters Into A Distribution Agreement With PETNET Solutions
Mitsubishi Tanabe Enters Into Co-Marketing Agreement With Bayer Yakuhin
MEDRAD Signs An Agreement With Abbott Point of Care
Bayer CropScience Enters Into Research Agreement With IVCC
Dyax Enters Into Agreement With Bayer Schering Pharma
Nektar Therapeutics Enters Into Co-Development Agreement With Bayer HealthCare
Bayer HealthCare Enters Into Co-Promotion Agreement With Intendis
Bayer Yakuhin Enters Into Agreement With Intendis
Novartis Signs An Agreement With Bayer Schering Pharma
KineMed Enters Into Co-Development Agreement With Bayer HealthCare
CSL Behring Enters Into Distribution Agreement With Bayer HealthCare
KINAXO Biotechnologies Enters Into A Licensing Agreement With Bayer Vital
Barr Labs Enters Into Licensing Agreement With Bayer
Bayer Pharma Enters Into Licensing Agreement With Dyax For Human Antibody Phage Display Library
Oxford Pharmascience Enters Into Licensing Agreement With Bayer Consumer Care
Spectrum Pharma Enters Into Licensing Agreement With Bayer Healthcare For Zevalin
Trius Therapeutics Enters Into Licensing Agreement With Bayer HealthCare For Torezolid Phosphate
Lead Discovery Enters Into Licensing Agreement With Bayer Schering
Stellar Biotechnologies Enters Into Licensing Agreement With Bayer Innovation
SentiSearch Enters Into Licensing Agreement With Bayer CropScience, Columbia University And Rockefeller University
Bayer Schering Enters Into Licensing Agreement With EndoCeutics
Prometheus Labs Signs Licensing Agreement With Bayer Schering Pharma
Fresenius Kabi Deutschland Extends Licensing Agreement With Bayer Schering Pharma
Cellectis Enters Into Licensing Agreement With Bayer HealthCare
Bayer Schering Enters Into Option Licensing Agreement With Compugen
Algeta Enters Into Licensing Agreement With Bayer For Alpharadin
Celera Enters Into Licensing Agreement With Bayer Schering Pharma
Fresenius Kabi Deutschland Enters Into Research And Licensing Agreement With Bayer Schering Pharma
Ardea Biosciences Enters Into License Agreement With Bayer HealthCare
GeneGo Extends Licensing Agreement With Bayer Schering Pharma
ImmunoGen Enters Into Licensing Agreement With Bayer HealthCare
Activaero Enters Into Licensing Agreement With Bayer HealthCare
Sonus Pharma Enters Into Licensing Agreement With Bayer Healthcare
Maxygen Enters Into License Agreement With Bayer HealthCare
Barr Labs Enters Into Licensing Agreement With Bayer For Yasmin And Yaz
Seattle Genetics Amends Licensing Agreement With Bayer HealthCare
ACT Biotech Enters Into Licensing Agreement With Bayer HealthCare
BioInvent International Signs Licensing Agreement With Bayer HealthCare
Millipore Enters Into Licensing Agreement With Bayer HealthCare
Bayer Schering Enters Into License Agreement With Taisho Pharma, Nihon Nohyaku And NIRS
Bayer Schering Enters Into Licensing Agreement With Philogen For L19-IL2
Bayer Schering Enters Into Licensing Agreement With Avid RadioPharma
ZymoGenetics Enters Into Licensing Agreement With Bayer Schering Pharma
Ariadne Extends License Agreement With Bayer
Syndax Pharma Enters Into Licensing Agreement With Bayer Schering Pharma
Aureus Pharma Enters Into Licensing Agreement With Bayer CropScience
CSL Behring Enters Into Licensing Agreement With Bayer
DelSiTech Enters Into License Agreement With Bayer Innovation For Drug Delivery Technology
Molecular Insight Enters Into An Licensing Agreement With Bayer Schering Pharma
Bayer Prices Public Offering Of Notes Due 2016 For US$259 Million
Bayer Holding Completes Public Offering Of 0.82% Corporate Bonds Due 2017 For US$363 Million
Bayer Holding Completes Public Offering Of 1.46% Corporate Bonds Due 2017 For US$109 Million
Bayer Completes Public Offering Of 4.625% Bond For US$1,776 Million
Bayer Completes Public Offering Of 4% Bonds For US$284 Million
Bayer Completes Public Offering Of 3.575% Bonds For US$170 Million
Bayer Completes Public Offering Of Floating Rate Bonds For US$94.11 Million
Bayer Completes Public Offering Of 1.585% Bonds For US$81.48 Million
Bayer Completes Public Offering Of 1.955% Bonds For US$122.23 Million
Bayer Completes Public Offering Of Floating Rate Bonds For US$244.45 Million
Bayer Completes Public Offering Of Fixed Rate Bonds For US$267 Million
Bayer Completes Public Offering Of Floating Rate Bonds For US$401 Million
Nordic Group To Acquire Trasylol From Bayer HealthCare
Piramal Healthcare Completes Acquisition Of Molecular Imaging Development Portfolio Of Bayer Pharma
Siemens Healthcare Diagnostics Completes Acquisition Of Manufacturing Plant In Mishawaka From Bayer HealthCare
Naari Acquires Visanne Brand From Bayer
VisEn Medical Acquires Fluorescent Imaging Intellectual Property From Bayer Schering Pharma
Genzyme Acquires Rights To Fludara And Leukine From Bayer HealthCare
Genzyme Acquires Rights To Campath From Bayer HealthCare
Genzyme Completes Acquisition Of Leukine Manufacturing Facility From Bayer HealthCare For US$98.5 Million
Axxam Acquires Molecular Screening Technologies From Bayer HealthCare
Bayer HealthCare Sells Its Plasma Products Business To Talecris BioTherapeutics
Siemens Medical Solutions Acquires Diagnostics Division Of Bayer Healthcare
Bayer To Acquire Conceptus, Contraceptive Devices Maker For US$1.1 Billion
Bayer HealthCare To Acquire Radimetrics, Healthcare Software Maker
Delpharm Completes Acquisition Of Bayer Sante Familiale, Consumer Care Division Of Bayer
Nomad Bioscience Acquires Icon Genetics From Bayer Innovation
MEDRAD Completes Acquisition Of Pathway Medical Technologies For US$125 Million
SuperGen Completes Acquisition Of Astex Therapeutics
Bayer MaterialScience Acquires Artificial Muscle
Bayer MaterialScience Completes Acquisition Of PolyBioMed From Lombard Medical Technologies
Bayer Acquires Remaining 49% Interest In Berlimed From Juste
Juste Acquires 51% Interest In Justesa Imagen From Bayer
Bayer HealthCare Completes Acquisition Of iSense
Bayer Acquires Minority Stake In Bayer Schering Pharma
Bayer HealthCare Acquires DIREVO Biotech
MEDRAD Completes Acquisition Of Possis Medical

LIST OF FIGURES

Bayer AG – Pipeline by Indication, 2013
Bayer AG – Pipeline by Stage of Development, 2013
Bayer AG – Monotherapy Products in Pipeline, 2013
Bayer AG – Combination Treatment Modalities in Pipeline, 2013
Bayer AG – Pipeline By Therapeutic Class, 2013
Bayer AG – Pipeline By Route of Administration, 2013
Bayer AG - Pipeline Products By Mechanism of Action, 2013

Ask Your Question

Bayer AG – Product Pipeline Review – 2013
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: